Depression is caused by identifiable changes in brain networks. We can restore healthy neural activity and relieve symptoms of depression.
Be the first to know when we launch. Select the group below that best describes you.
HealthcareDepression is caused by identifiable changes in brain networks. We can restore healthy neural activity and relieve symptoms of depression.
Be the first to know when we launch. Select the group below that best describes you.
HealthcareSAINT Neuromodulation System receives FDA clearance
We are at the forefront of a significant improvement in the care of treatment-resistant depression. The FDA clearance for the SAINT Neuromodulation System is a major milestone in Magnus' long-term journey to restore and sustain mental health. Read the Press Release.
FDA awards Breakthrough Device Designation
The FDA has awarded Breakthrough Device Designation to Magnus Medical’s non-invasive technology to rapidly treat major depressive disorder (MDD) in adults who have not responded to antidepressant medication.
Patrick J. Kennedy writes about a watershed moment brought about by neuroscientists to gain ground against diseases of the brain. Read the article.
SAINT therapy identifies the optimal target to affect brain circuitry by using breakthrough algorithms with structural and functional neuroimaging for personalized targeting.
Precise patterns of stimulation, leveraging recent advances in neuroscience, can restore these circuits and yield significant decrease in depressive symptoms.
Magnus Medical is creating the next generation of neuromodulation technology to improve quality of life rapidly and effectively.
Our team is growing. We are looking for individuals who are personally and boldly committed to improving treatment for mental health. Please view our open positions HERE.